25 Jan LAKEWOOD-AMEDEX APPOINTS TWO NEW BOARD MEMBERS
Elects Thomas Pfisterer and Douglas Manion, MD, FRCP(C), to the Board of Directors SARASOTA, Fla., January 25, 2022 — Lakewood-Amedex Inc., a privately held, clinical stage pharmaceutical discovery and development company advancing a broad portfolio of first-in-class antimicrobial and antifungal therapeutics called Bisphosphocins®, today announced that two new...